Sofinnova Venture Partners X, L.p. - Net Worth and Insider Trading
Sofinnova Venture Partners X, L.p. Net Worth
The estimated net worth of Sofinnova Venture Partners X, L.p. is at least $360 Million dollars as of 2024-05-05. Sofinnova Venture Partners X, L.p. is the 10% Owner of CinCor Pharma Inc and owns about 6,073,949 shares of CinCor Pharma Inc (CINC) stock worth over $177 Million. Sofinnova Venture Partners X, L.p. is the 10% Owner of Vera Therapeutics Inc and owns about 3,467,156 shares of Vera Therapeutics Inc (VERA) stock worth over $151 Million. Sofinnova Venture Partners X, L.p. is also the 10% Owner of Akouos Inc and owns about 1,515,073 shares of Akouos Inc (AKUS) stock worth over $20 Million. Besides these, Sofinnova Venture Partners X, L.p. also holds Inozyme Pharma Inc (INZY) , Bolt Biotherapeutics Inc (BOLT) . Details can be seen in Sofinnova Venture Partners X, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sofinnova Venture Partners X, L.p. has not made any transactions after 2023-02-06 and currently still holds the listed stock(s).
Transaction Summary of Sofinnova Venture Partners X, L.p.
Sofinnova Venture Partners X, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Venture Partners X, L.p. owns 6 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Bolt Biotherapeutics Inc (BOLT) among others .
Insider Ownership Summary of Sofinnova Venture Partners X, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2020-07-28 | 10 percent owner |
| AKUS | Akouos Inc | 2020-06-30 | 10 percent owner |
| BOLT | Bolt Biotherapeutics Inc | 2021-02-09 | 10 percent owner |
 | | 2021-06-29 | 10 percent owner |
| | 2023-02-06 | 10 percent owner |
| | 2022-08-11 | 10 percent owner |
Sofinnova Venture Partners X, L.p. Latest Holdings Summary
Sofinnova Venture Partners X, L.p. currently owns a total of 5 stocks. Among these stocks, Sofinnova Venture Partners X, L.p. owns 6,073,949 shares of CinCor Pharma Inc (CINC) as of August 11, 2022, with a value of $177 Million and a weighting of 49.04%. Sofinnova Venture Partners X, L.p. owns 3,467,156 shares of Vera Therapeutics Inc (VERA) as of February 6, 2023, with a value of $151 Million and a weighting of 41.85%. Sofinnova Venture Partners X, L.p. also owns 1,515,073 shares of Akouos Inc (AKUS) as of June 30, 2020, with a value of $20 Million and a weighting of 5.59%. The other 2 stocks Inozyme Pharma Inc (INZY) , Bolt Biotherapeutics Inc (BOLT) have a combined weighting of 3.51% among all his current holdings.
Latest Holdings of Sofinnova Venture Partners X, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CINC | CinCor Pharma Inc | 2022-08-11 | 6,073,949 | 29.06 | 176,508,958 |
| VERA | Vera Therapeutics Inc | 2023-02-06 | 3,467,156 | 43.44 | 150,613,257 |
| AKUS | Akouos Inc | 2020-06-30 | 1,515,073 | 13.29 | 20,135,320 |
| INZY | Inozyme Pharma Inc | 2020-07-28 | 2,028,308 | 4.74 | 9,614,180 |
| BOLT | Bolt Biotherapeutics Inc | 2021-02-09 | 2,754,437 | 1.10 | 3,029,881 |
Holding Weightings of Sofinnova Venture Partners X, L.p.
Sofinnova Venture Partners X, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Sofinnova Venture Partners X, L.p. has made a total of 2 transactions in CinCor Pharma Inc (CINC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in CinCor Pharma Inc is the acquisition of 500,000 shares on August 11, 2022, which cost Sofinnova Venture Partners X, L.p. around $15 Million.
According to the SEC Form 4 filings, Sofinnova Venture Partners X, L.p. has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vera Therapeutics Inc is the acquisition of 285,714 shares on February 6, 2023, which cost Sofinnova Venture Partners X, L.p. around $2 Million.
According to the SEC Form 4 filings, Sofinnova Venture Partners X, L.p. has made a total of 1 transactions in Akouos Inc (AKUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akouos Inc is the acquisition of 58,823 shares on June 30, 2020, which cost Sofinnova Venture Partners X, L.p. around $999,991.
More details on Sofinnova Venture Partners X, L.p.'s insider transactions can be found in the Insider Trading History of Sofinnova Venture Partners X, L.p. table.Insider Trading History of Sofinnova Venture Partners X, L.p.
- 1
Sofinnova Venture Partners X, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Sofinnova Venture Partners X, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sofinnova Venture Partners X, L.p. is 0.44%. GuruFocus also compares Sofinnova Venture Partners X, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Sofinnova Venture Partners X, L.p. within 3 months outperforms 4 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sofinnova Venture Partners X, L.p.'s insider trading performs compared to the benchmark.
Performance of Sofinnova Venture Partners X, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.35 | | | | | |
| Relative Return to S&P 500(%) | 20.88 | | | | | |
Sofinnova Venture Partners X, L.p. Ownership Network
Sofinnova Venture Partners X, L.p. Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Sofinnova Venture Partners X, L.p. is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Sofinnova Venture Partners X, L.p. made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Sofinnova Venture Partners X, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Sofinnova Venture Partners X, L.p.. You might contact Sofinnova Venture Partners X, L.p. via mailing address: 3000 Sand Hill Road, 4-250, Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
